NiXEN Partners’ most common sectors for investment arebusiness services (10%) and construction (10%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (47%) and secondary buyout (27%). In total, NiXEN Partners has invested in 2 different countries.
Sign-up to view NiXEN Partners’ full profile and discover more middle-market private equity firm investors just like it.
38 Bis rue d’Artois,
Paris,
75008
France
+33 (0)1 75 77 46 00
www.nixen.com
contact@nixen.com
| Status | Dates | Company | Description | |||||
|---|---|---|---|---|---|---|---|---|
| Investment | Exit | |||||||
| Current | 2022-10-26 | - |
Unither Pharmaceuticals
Life Science Amiens, France www.unither-pharma.com 1,500 |
Unither Pharmaceuticals is a developer and manufacturer of pharmaceuticals products. Unither operates six manufacturing sites in France, the United States, and Brazil, and has a dedicated research and development center in Europe. Unither Pharmaceuticals was founded in 1993 and is based in Amiens, France.
|
||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
